Possible antiarrhythmic activities of trapidil

Area of Science:

• Pharmacology
• Cardiovascular Physiology

Background:

• Ventricular arrhythmias pose a significant threat to cardiovascular health.
• Identifying novel antiarrhythmic agents is crucial for managing cardiac rhythm disorders.

Purpose of the Study:

• To investigate the potential antiarrhythmic activities of 5-methyl-7-diethylamino-s-triazolo(1,5-a)pyrimidine (trapidil).

Main Methods:

• In vitro and in vivo studies were conducted using animal models (rats, guinea pigs, dogs) and isolated rabbit ventricular muscle cells.
• Arrhythmias were induced using pharmacological agents (aconitine, ouabain) and electrical stimulation under myocardial ischemia.
• Electrophysiological parameters including action potential duration (APD) and effective refractory period (ERP) were measured.

Main Results:

• Trapidil significantly increased the dose of inducers required to produce ventricular arrhythmias in rats and guinea pigs.
• In dogs with acute myocardial ischemia, trapidil raised the threshold current for electrically induced ventricular tachycardia.
• Electrophysiological studies revealed that trapidil shortened APD and prolonged ERP in isolated ventricular cells, increasing the ERP/APD ratio.

Conclusions:

• Trapidil exhibits promising antiarrhythmic properties.
• The drug's ability to modulate action potential duration and refractoriness suggests efficacy in inhibiting ventricular arrhythmias.